An investigation into the prescribed daily dose of fluoxetine

South African Medical Journal

Volumn 87, Issue 12 SUPPL., 1997, Pages 1738-1743

  Truter, Ilse ^a   Kotze, Theunis J Van W ^a  

^a NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042581950     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Szuba TJ, Westerholm B. Studies on drug utilization: bilateral case study in Poland and Sweden. Soc Sci Med 1989; 29(12): 1363-1366.
2. Capellà D. Descriptive tools and analysis. In: Dukes MNG, ed. Drug Utilization Studies: Methods and Uses. WHO Regional Publications, European Series, No. 45, 1993; 55-78.
3. Serradell J, Bjornson DC, Hartzema AG. Drug utilization study methodologies: national and international perspectives. Drug Intell Clin Pharm 1987; 21: 994-1001.
4. Feldman HI, Strom BL. Utilisation of drugs for diabetes mellitus. Drug Safety 1991; 6(3): 220-229.
5. Sjövist F, Agenas I. Drug utilization studies: implications for medical care. Acta Med Scand 1984; 603: 1.
6. The selective serotonin re-uptake inhibitors - a review and new uses. Medifile. Johannesburg: TPS Drug Information Centre, 1995; 9(9): 65-68.
7. Van Rooyen RJ, Snyman JR, eds. MIMS Medical Specialities. Pretoria: Times Media Limited, August 1995; 35(8).
8. Lockwood A. Berbatis CG. Psychotropic drugs in Australia. Med J Aust 1990; 153: 604-611.
9. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, March 1995: 29.
10. World Health Organisation. Anatomical Therapeutic Chemical (ATC) Classification Index Including Defined Daily Doses (DDDs) for Plain Substances. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, January 1995.